BA
NXTM

BlackRock Advisors’s NxStage Medical Inc. NXTM Stock Holding History

BlackRock Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.08M Buy
193,987
+25,165
+15% +$622K 0.01% 1133
2016
Q3 		$4.22M Buy
168,822
+110,952
+192% +$2.59M ﹤0.01% 1178
2016
Q2 		$1.25M Buy
57,870
+865
+2% +$15.4K ﹤0.01% 1664
2016
Q1 		$855K Buy
57,005
+10,352
+22% +$173K ﹤0.01% 1819
2015
Q4 		$1.02M Buy
46,653
+6,511
+16% +$121K ﹤0.01% 1696
2015
Q3 		$633K Sell
40,142
-1,181
-3% -$18.9K ﹤0.01% 2019
2015
Q2 		$590K Buy
41,323
+2,282
+6% +$38.6K ﹤0.01% 2059
2015
Q1 		$675K Buy
39,041
+5,832
+18% +$103K ﹤0.01% 1846
2014
Q4 		$595K Sell
33,209
-1,523
-4% -$24.5K ﹤0.01% 1868
2014
Q3 		$456K Sell
34,732
-726
-2% -$9.78K ﹤0.01% 2049
2014
Q2 		$510K Sell
35,458
-5,159
-13% -$67.4K ﹤0.01% 2010
2014
Q1 		$517K Buy
40,617
+1,986
+5% +$25.9K ﹤0.01% 2022
2013
Q4 		$386K Buy
38,631
+2,879
+8% +$32.7K ﹤0.01% 2236
2013
Q3 		$470K Buy
35,752
+846
+2% +$11.1K ﹤0.01% 1954
2013
Q2 		$498K Buy
+34,906
New +$439K ﹤0.01% 1833

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's NXTM Position: Q4 2016 in Review

BlackRock Advisors increased its NxStage Medical Inc. (NXTM) stake by 15% in Q4 2016, buying an estimated $622K and bringing the position to 193,987 shares worth $5.08M. The position accounts for 0.01% of the portfolio, ranked #1133.

BlackRock Advisors first reported a position in NXTM in Q2 2013 and has held it in 15 quarters since. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • BlackRock Advisors held 193,987 shares of NxStage Medical Inc. worth $5.08M as of Q4 2016.
  • BlackRock Advisors bought 25,165 NxStage Medical Inc. shares in Q4 2016, an estimated $622K.
  • NxStage Medical Inc. made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1133 holding.
  • BlackRock Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 15 quarters since.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.